Modern Nation States are complex systems that today suffer from the affliction of terrorism, which can attack its vital centers and connective tissue. Even as nation’s try to counter, terrorists are themselves evolving and seeking new capabilities to more effectively injure their hosts, including all forms of weapons of mass destruction (WMD).

Bio-terrorism has emerged in recent years as a key challenge for European security. To respond to this threat, the European Union (EU) has engaged in the endeavour of preventing and protecting from possible bioterrorist attacks, fostering preparedness in its Member States through a comprehensive approach.

On the August 18, 2008, a meeting of experts on bio-weapons was held in Geneva. The meeting considered (i) national regional and international measures to improve bio-safety and bio-security, including laboratory safety and security of pathogens and toxins and (ii) oversight, education, awareness raising and adoption and/ or development of codes of conduct with the aim of preventing misuse in the context of advances in bioscience and bio-technology research with the potential of use for purposes prohibited by the Convention (the BTWC).

Even terrorists play pranks on WMD use these days! Late May 2008 a purported terrorist video caught media attention and some serious coverage.

The process of globalisation has been understood as "time-space" compression1. Structurally, the boundaries that separate human conditions are now diminishing, enabled by rapid interaction. Philosophically, globalisation has led to the emergence of global human conscience.

In June 2002, the first ever big delegation led by Dr AC Muthiah, the Senior Vice President of FICCI, left for the United States. The two interesting features of this meticulously planned visit by Dr Amit Mitra, the Secretary General of FICCI were first, the unusual difficulty experienced in political clearance owing to the ongoing India-Pakistan stand off. Second, in the US it was not the expected Information Technology (IT) sector that received attention, but the Biotechnological (BT) Companies like Ranbaxy, Biocon India, and Cadila among others, who stole the limelight.